D-Wave Quantum (QBTS)

D-Wave Quantum (QBTS)

Prezzo: 23.37

Società e modello di business

D-Wave Quantum specializes in quantum computing technology, offering products and services that enable businesses to solve complex problems through quantum algorithms. Its core offerings include quantum processors and software tools designed for optimization, machine learning, and simulation tasks. The company primarily generates revenue from licensing its quantum computing platforms and providing cloud-based access to its technology, targeting sectors such as finance, logistics, and pharmaceuticals.

Profilo di investimento

The investment profile of D-Wave Quantum is more aligned with growth investors, given its focus on innovative technology and potential market expansion. The company does not currently provide dividends, and its financial metrics suggest a higher risk profile. Investors may find it suitable for medium to long-term horizons, considering the volatility and growth potential associated with emerging technologies.

Sito ufficiale

Metriche fondamentali (sperimentale)

EPS (TTM) — utile per azione degli ultimi 12 mesi, $
-1.15 Rischio
Ricavi QoQ — crescita dei ricavi trimestre su trimestre
3.9%
Sorpresa EPS
37.5% meglio del previsto
Volatilità 20g
10.0% normal
Dati FMP / FinFeed aggiornati: 2026-06-12
Racc.: Mantieni Potenziale: 55 Rischio: 69 Aggiornato: 2026-06-13 02:45
Come funziona la raccomandazione
Perché l'AI la pensa così:
Weak momentum and high risk; cautious approach advised.

Traccia in portafoglio

Grafico prezzo

Raccomandazione AI Previsione analista Evento calendario Segnale positivo Segnale negativo Neutrale / aggiornamento Mantieni / informativo B My buy S My sell
Cambiamenti di raccomandazione AI
Data Prima Dopo Motivo
2026-05-10 02:48 Vendi Mantieni Weak fundamentals and high volatility raise concerns.
2026-05-08 15:23 Vendi scenario_deterioration
2026-05-08 05:37 Mantieni Mantieni Компания D-Wave Quantum демонстрирует высокую волатильность и нестабильные финансовые показатели, что увеличивает риск инвестиций. Тем не менее, недавний рост на 58.62% за 20 дней может указывать на потенциальные возможн
Previsioni analisti
Data Analista Action Target Prezzo allora
2026-06-02 11:05 Stifel Nicolaus Aggiorna — → 35 29.18
2026-05-13 11:20 Canaccord Genuity Target abbassato 43 → 41 22.34
2026-05-13 10:58 Mizuho Securities Target abbassato 31 → 29 22.34
D-Wave Quantum (QBTS) Rigetti Computing Alexandria Real Estate American Tower

Biotech and Real Estate Sectors Show Mixed Performance Ahead of Key Oncology Meeting

The upcoming meeting of the American Society of Clinical Oncology is poised to influence biotech stocks, which have shown significant gains over the past year despite recent fluctuations. Additionally, a substantial government investment in quantum computing has sparked notable stock increases in that sector.